GSI 250 (Viread 250 mg)
Generic Name: tenofovir
Pill with imprint GSI 250 is White, Capsule-shape and has been identified as Viread 250 mg. It is supplied by Gilead Sciences, Inc.
Viread is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 250
Viread
- Generic Name
- tenofovir
- Imprint
- GSI 250
- Strength
- 250 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-0406
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
lactose monohydrate,
microcrystalline cellulose,
magnesium stearate,
titanium dioxide,
triacetin,
hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
More about Viread (tenofovir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (13)
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.